• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Enoxacin absorption and elimination characteristics.

作者信息

Toothaker R D

机构信息

Parke Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan.

出版信息

Clin Pharmacokinet. 1989;16 Suppl 1:52-8. doi: 10.2165/00003088-198900161-00009.

DOI:10.2165/00003088-198900161-00009
PMID:2653697
Abstract

Enoxacin, a new fluoroquinolone antibiotic, is rapidly and extensively absorbed after oral administration and has a bioavailability independent of dose and only slightly delayed by concurrent food. Plasma concentrations are similar for both intravenous and oral administration. The t1/2 for enoxacin ranges from 4 to 6 hours, which allows effective twice-daily administration without significant accumulation. Plasma enoxacin concentrations may be slightly higher in elderly subjects, but this change does not necessitate dosage adjustment in older patients with adequate renal function. Enoxacin and ciprofloxacin decrease the clearance of coadministered theophylline, whereas ofloxacin does not appear to greatly alter methylxanthine clearance. Maalox (a magnesium-aluminium hydroxide antacid) significantly decreases the oral bioavailability of ciprofloxacin, ofloxacin and enoxacin, and use of these agents with antacids should be avoided. Enoxacin is a highly effective oral anti-infective agent with excellent bioavailability characteristics, a relatively slow rate of elimination and simple, well-defined requirements for dosage modification in patients with renal dysfunction.

摘要

相似文献

1
Enoxacin absorption and elimination characteristics.
Clin Pharmacokinet. 1989;16 Suppl 1:52-8. doi: 10.2165/00003088-198900161-00009.
2
Inhibition of enoxacin absorption by antacids or ranitidine.抗酸剂或雷尼替丁对依诺沙星吸收的抑制作用。
Antimicrob Agents Chemother. 1989 May;33(5):615-7. doi: 10.1128/AAC.33.5.615.
3
Effect of oral antacids on disposition of intravenous enoxacin.口服抗酸剂对静脉注射依诺沙星处置的影响。
Antimicrob Agents Chemother. 1993 Apr;37(4):775-7. doi: 10.1128/AAC.37.4.775.
4
Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.对健康志愿者口服400毫克剂量莫西沙星后,抗酸剂和H2拮抗剂对其吸收影响的评估。
Clin Pharmacokinet. 2001;40 Suppl 1:39-48. doi: 10.2165/00003088-200140001-00006.
5
Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.喹诺酮类药物在志愿者体内的药代动力学:拟议的给药方案。
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S83-9.
6
Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin.
J Clin Pharmacol. 1993 Jan;33(1):53-6. doi: 10.1002/j.1552-4604.1993.tb03903.x.
7
Enoxacin: a new fluoroquinolone.
Clin Pharm. 1989 Feb;8(2):97-107.
8
Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.依诺沙星:对其治疗泌尿生殖道感染临床疗效的重新评估。
Drugs. 1996 Jan;51(1):137-60. doi: 10.2165/00003495-199651010-00009.
9
The clinical pharmacokinetics of levofloxacin.左氧氟沙星的临床药代动力学。
Clin Pharmacokinet. 1997 Feb;32(2):101-19. doi: 10.2165/00003088-199732020-00002.
10
Drug-drug interactions affecting fluoroquinolones.影响氟喹诺酮类药物的药物相互作用。
Am J Med. 1989 Dec 29;87(6C):47S-51S.

引用本文的文献

1
Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.依诺沙星及其代谢产物氧氟沙星在健康志愿者排泄液中的分布动力学
Antimicrob Agents Chemother. 1995 Sep;39(9):2092-7. doi: 10.1128/AAC.39.9.2092.
2
Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.老年复杂性尿路感染患者静脉注射至口服依诺沙星的药代动力学和生物利用度
Antimicrob Agents Chemother. 1990 Oct;34(10):1966-72. doi: 10.1128/AAC.34.10.1966.

本文引用的文献

1
The effect of food on drug bioavailability.食物对药物生物利用度的影响。
Annu Rev Pharmacol Toxicol. 1980;20:173-99. doi: 10.1146/annurev.pa.20.040180.001133.
2
The pharmacokinetics and tissue penetration of ofloxacin.氧氟沙星的药代动力学和组织穿透性。 (注:原文中多了一个of,正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin )
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
3
Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.新型抗菌药物培氟沙星在人体的剂量依赖性药代动力学研究。
J Pharm Sci. 1984 Oct;73(10):1379-82. doi: 10.1002/jps.2600731014.
4
The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.依诺沙星在健康志愿者中的临床药代动力学及耐受性
J Antimicrob Chemother. 1984 Sep;14 Suppl C:63-9. doi: 10.1093/jac/14.suppl_c.63.
5
Pharmacokinetics of norfloxacin in renal failure.诺氟沙星在肾衰竭患者中的药代动力学
J Antimicrob Chemother. 1984 Oct;14(4):439. doi: 10.1093/jac/14.4.439.
6
Norfloxacin disposition after sequentially increasing oral doses.依次增加口服剂量后诺氟沙星的处置情况。
Antimicrob Agents Chemother. 1983 Feb;23(2):284-8. doi: 10.1128/AAC.23.2.284.
7
High-performance liquid chromatography and preliminary pharmacokinetics of enoxacin and its 4-oxo metabolite in human plasma, urine and saliva.依诺沙星及其4-氧代代谢物在人血浆、尿液和唾液中的高效液相色谱分析及初步药代动力学研究
J Chromatogr. 1985 Oct 11;343(2):449-54. doi: 10.1016/s0378-4347(00)84618-6.
8
Difloxacin metabolism and pharmacokinetics in humans after single oral doses.单次口服剂量后地氟沙星在人体内的代谢及药代动力学
Antimicrob Agents Chemother. 1986 Nov;30(5):689-93. doi: 10.1128/AAC.30.5.689.
9
Pharmacokinetic aspects of drug therapy in the elderly.老年人药物治疗的药代动力学方面。
Ther Drug Monit. 1986;8(3):249-55. doi: 10.1097/00007691-198609000-00001.
10
The influence of quinolone derivatives on theophylline clearance.喹诺酮衍生物对茶碱清除率的影响。
Br J Clin Pharmacol. 1986 Dec;22(6):677-83. doi: 10.1111/j.1365-2125.1986.tb02957.x.